<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Sama Kadakia on Medium]]></title>
        <description><![CDATA[Stories by Sama Kadakia on Medium]]></description>
        <link>https://medium.com/@sama.kadakia?source=rss-7fa723e00fae------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*Bc-cTYm9-iP7NQoROVpJwg.jpeg</url>
            <title>Stories by Sama Kadakia on Medium</title>
            <link>https://medium.com/@sama.kadakia?source=rss-7fa723e00fae------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Fri, 20 Nov 2026 00:02:26 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@sama.kadakia/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Rethinking Employer Sponsored Health Insurance — Part 1: the Benefit Leader’s Impossible Job]]></title>
            <link>https://medium.com/@sama.kadakia/rethinking-employer-sponsored-health-insurance-part-1-the-benefit-leaders-impossible-job-85394a16bf1f?source=rss-7fa723e00fae------2</link>
            <guid isPermaLink="false">https://medium.com/p/85394a16bf1f</guid>
            <category><![CDATA[healthcare-innovations]]></category>
            <category><![CDATA[employee-benefits]]></category>
            <category><![CDATA[health-insurance]]></category>
            <dc:creator><![CDATA[Sama Kadakia]]></dc:creator>
            <pubDate>Mon, 17 Aug 2026 20:07:24 GMT</pubDate>
            <atom:updated>2026-08-17T20:07:24.488Z</atom:updated>
            <content:encoded><![CDATA[<h3>Rethinking Employer Sponsored Health Insurance — Part 1: The Benefit Leader’s Impossible Job</h3><p><em>By Sama Kadakia</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*SOggzTMCQgApLvDc9gp2Ow.png" /></figure><p>It’s April. You’re a benefits leader at a company with 2,000 employees. Your health plan is up for renewal. The bill is <strong>9% higher</strong> than last year…again<strong>.</strong></p><p>So you launch an RFP and ask the market, “<em>How do we get our healthcare costs under control?”</em></p><p>Twenty vendors tell you how they are going to save you money. One offers narrower networks and higher deductibles. Another promises to find billing errors. Yet another claims to better manage your population via a new app, clinical program, or advocacy solution.</p><p>Everyone promises savings. In the back of your mind, you wonder, <em>“if these solutions are working, why does my bill keep going up?”</em></p><p>You can perform the best due diligence, pick the exact right vendors, negotiate hard, and implement these benefits flawlessly. Despite your best efforts, you’ll probably end up in the same place at the next renewal cycle, doing it all over again. Maybe you managed to bend next year’s increase from 8% to 6%.</p><p>That’s a win…but you’re still paying more than last year’s unaffordable costs. As a benefit leader, you are literally tasked with an impossible job.</p><p><strong>First, you’re being asked to pick one health plan for 2,000 very different people.</strong></p><p>… a 28-year old that rarely sees a doctor<br>… a 45-year old managing diabetes<br>… a family with two young children<br>… someone going through cancer<br>… someone who just moved across the country</p><p>One benefit design has to meet everyone’s needs.</p><p><strong>Second, the highest ROI investments take years to pay off.</strong></p><p>Many of the most expensive health conditions don’t appear overnight. They develop over years. They require early and consistent long-term investments to meaningfully effect outcomes: primary care, prevention, medication adherence, and lifestyle interventions.</p><p>Investing in the right things today may not yield results for 3, 5, or 10 years even. Today’s expensive medication avoids long-term complications (and costs). The intensive chronic risk management programs today prevent a future strokes or heart attacks, yielding an impressive 10:1 ROI….in 10–15 years.</p><p>By then, your employee has left for another job and someone else captured your ROI. We’re trying to solve a <em>decades-long</em><strong> </strong><em>problem</em> with a series of <em>short-term investments</em>.</p><p><strong>Third, you’re holding the checkbook but have little control over how it gets spent.</strong></p><p>You decide how much to contribute toward your employees’ healthcare based on their needs, your budget, and the profile of talent you want to attract and retain. You have no control over prices, consumption patterns, or quality.</p><p>Will an employee use the ED or urgent care? Will they engage in prevention or wait until a manageable condition becomes complex? Will they use an ASC or a hospital?</p><p>When costs go up, you’re stuck with variations of just a handful of controls….increasing employee cost share, tightening the network, increasing payment integrity rigor, redesigning benefits to steer members to lower cost, higher value care. Each can help but are ultimately a marginal optimization of how dollars are spent.</p><p><strong>As healthcare affordability reaches a tipping point, can we achieve the impossible?</strong></p><p>Can we actually achieve a flat (and potentially declining) healthcare cost trend? I believe we can, but only by rethinking some fundamental design choices in employer-sponsored health insurance. ICHRA may give us the infrastructure to do it. <br> <br> In the next series of posts, I explore these fundamental design changes and what a new model of employer-sponsored health insurance could look like. Check it out and let me know your thoughts!</p><p><strong><em>Part 2: What would change if a health plan was portable and stuck with employees for 10 years instead of 12 months? (coming soon)</em></strong></p><p><strong><em>Part 3: What would change if members could share a more meaningful stake in the value they create (or don’t create) with their behaviors? (coming soon)</em></strong></p><p><strong><em>Part 4: Putting it together — what would a better model look like and how might ICHRA make this possible? (coming soon)</em></strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=85394a16bf1f" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Is direct-to-employer a growth engine or costly distraction for health systems?]]></title>
            <link>https://medium.com/zs-associates/is-direct-to-employer-a-growth-engine-or-costly-distraction-for-health-systems-42044ac47491?source=rss-7fa723e00fae------2</link>
            <guid isPermaLink="false">https://medium.com/p/42044ac47491</guid>
            <category><![CDATA[affordability]]></category>
            <category><![CDATA[healthcare-strategies]]></category>
            <category><![CDATA[employer]]></category>
            <category><![CDATA[innovation]]></category>
            <category><![CDATA[health-systems]]></category>
            <dc:creator><![CDATA[Sama Kadakia]]></dc:creator>
            <pubDate>Mon, 20 Apr 2026 22:40:01 GMT</pubDate>
            <atom:updated>2026-04-20T22:40:01.074Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*9cL1Ahi5ZI26eW_zQWqfWQ.jpeg" /></figure><p>By <a href="https://www.linkedin.com/in/samakadakia/">Sama Kadakia</a>, <a href="https://www.linkedin.com/in/kim-quigley-696a9bb/">Kim Quiqley</a>, <a href="https://www.linkedin.com/in/tinachaudhry/">Tina Chaudhry</a> and <a href="https://www.linkedin.com/in/vickyzhouphd/">Vicky Zhou, PhD</a></p><p>For decades, health systems have treated employers as wallets and not the customer. Health systems used commercial reimbursement to cross-subsidize government underpayments, while centering strategic plans on capacity, service line growth and payer negotiations. <br> <br>That era is changing. Health system margins are tightening amid Medicaid pressure, population shifts to Medicare, rise of VBC program participation, and more aggressive payer tactics. At the same time, employers are absorbing unsustainable cost growth — driven by GLP-1s, specialty drugs, higher utilization and shifting risk pools.</p><p>As employers push for more predictable costs and better workforce outcomes, health system leaders are increasingly asking:</p><p><strong>Is direct-to-employer a real strategic growth opportunity, or just noise?</strong></p><p>The answer: Direct-to-employer (DTE) is not a guaranteed, universal growth engine for all systems in all markets. Health systems that are willing to build the right capabilities are seeing it become an enduring growth enabler. Health systems that treat it as a side-project struggle to capture value.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/975/1*FibXhh46GEPNajVRHV7lLw.png" /></figure><h3><strong>What employers buy</strong></h3><p>According to recent ZS interviews with a dozen benefit consultants, it’s clear that employers are generally not shopping for access to healthcare services at the lowest unit prices. Although employers and unions are not a monolith, most want value, which generally includes:</p><ul><li>A healthy and productive workforce</li><li>Predictable budget-able healthcare spend and lower total cost of care</li><li>Reliable access and fast recovery times for their employees</li><li>Transparency and accountability for outcomes</li></ul><p>As employers grapple with 8%–10% annual cost growth, their buyer expectations are reshaping the market in three important ways:</p><ol><li><strong>Employers are steering volume: </strong>Variable copay plans and “value-based” benefit designs push employees toward lower-cost, higher-performing providers. Health systems that cannot demonstrate value lose share.</li><li><strong>High-cost specialties are being carved out: </strong>Bundled payment models and specialty Centers of Excellence (CoE) networks are shifting musculoskeletal, oncology and other high-margin services into narrow employer-directed arrangements.</li><li><strong>Virtual-first models are redefining access: </strong>Employers are adopting virtual-first disruptors to improve outcomes, reduce unnecessary surgery, optimize site-of-care, and improve convenience — often outside traditional health system networks.</li></ol><p>The implication is clear: Employers are increasingly acting as <em>active purchasers of healthcare</em> performance, not passive premium payers.</p><h3><strong>The promise of DTE and where health systems typically fall short</strong></h3><p>On paper, DTE is attractive:</p><ul><li>Stronger commercial payer mix</li><li>Reduced payer dependence</li><li>Direct employer relationships</li><li>Protection against disruptors</li></ul><p>In practice, most systems struggle to move beyond pilots or generate meaningful financial returns. DTE is not simply a contracting exercise. It requires building new capabilities that health systems have not historically prioritized. Systems that succeed in DTE tend to get five things right: <br> <br><strong>1) Enabling benefit, network and access design</strong></p><p>Even the strongest clinical offerings will underperform if they are not positioned correctly within benefit design, network and access structures that influence how employees seek care. For example, adoption may lag if not advantaged through:</p><ul><li>Significant affordability differentials for the member’s out-of-pocket spend</li><li>Preferred network status</li><li>Protected capacity and fast-turnaround appointments</li></ul><p>Systems that overlook these structural drivers often see limited adoption and muted returns.</p><p><strong>2) Build go-to-market and commercial muscle</strong> <br>Winning employer business requires a B2B sales engine, not payer negotiations. That means:</p><ul><li>Understanding and engaging the local employer/union landscape</li><li>Navigating long sales cycles</li><li>Building relationships with TPAs and consultants</li><li>Managing accounts beyond initial contract</li></ul><p>Most systems underestimate this lift.</p><p><strong>3) Implement service and navigation infrastructure</strong></p><p>Employers expect responsiveness, coordination and accountability, not just access to clinicians. This can mean:</p><ul><li>Dedicated navigation</li><li>Proactive outreach and engagement</li><li>Transparent performance reporting</li><li>Partner integration</li><li>Rapid issue resolution</li></ul><p>Clinical excellence alone does not translate to employer satisfaction. <br> <br><strong>4) Outcomes and cost transparency</strong></p><p>Employer relationships require a higher level of measurement than most service lines are accustomed to providing. Employers want to see:</p><ul><li>Employee engagement and satisfaction (NPS)</li><li>Total cost of care and utilization trends</li><li>Clinical outcomes</li><li>Productivity impact</li></ul><p>Health systems that underinvest in reporting infrastructure will struggle to prove their value.</p><p><strong>5) Enterprise commitment</strong></p><p>DTE fails when it is treated as a side project. Successful systems ensure:</p><ul><li>Clear goals and ROI thresholds</li><li>Dedicated leadership</li><li>Separate governance from core service line priorities</li></ul><p>Without executive commitment, DTE rarely scales to the 100–200K lives threshold to realize meaningful economics.</p><h3><strong>How health systems are winning in DTE</strong></h3><p>Although there is no single playbook, three successful systems share a common theme: They started with employer needs and leaned into their unique strengths.</p><p><strong>Example 1: Find an anchor employer customer </strong><br>A $12B northeast system began with one large employer, building a tailored portfolio of solutions. Once proof points were established, they scaled to 35 employers — generating ~$80M in enterprise value and improving commercial mix.</p><p><em>Lesson: Harden the model with one anchor customer before broad expansion.</em></p><p><strong>Example 2: Start with your own employees</strong> <br>A $15B southern system launched DTE solutions internally, refining digital infrastructure and care models on its own workforce before commercializing via a for-profit newco. This created scalable, diversified revenue streams and new employer contracts.</p><p><em>Lesson: Use your employee base as a proving ground.</em></p><p><strong>Example 3: Differentiate through specialty excellence</strong></p><p>A $10B cancer center in the west partnered with a regional employer coalition to provide second-opinion and clinical decision support services, leaning on their strength as an NCI-designated hospital with evidence-based clinical protocols. Investments were stage-gated based on financial and adoption metrics. Strong outcomes and brand elevation ultimately supported national employer adoption and a broader cancer network strategy.</p><p><em>Lesson: Specialized differentiation can create employer pull beyond your local market.</em></p><h3><strong>A practical diagnostic: Is DTE right for your health system?</strong></h3><p>Importantly, DTE is not a universal growth lever for all systems and markets. Before investing, health system leaders should ask five simple questions:</p><ol><li>Is the commercial opportunity large enough, and growing?</li><li>Are there 1–3 anchor employers capable of supporting meaningful scale?</li><li>Does your system’s care delivery footprint overlap with where the employees of your target employer customers live?</li><li>Do you have a clear differentiation relative to competitors and virtual entrants, whether it’s access, pricing, outcomes or specialty services?</li><li>Is your organization willing to invest in building employer-grade capabilities (solutions, sales, servicing, analytics, partnerships, risk management and governance) to succeed?</li></ol><p>If the answer to several of these questions is “no,” DTE is likely a costly distraction.</p><h3><strong>Getting started: Defining and launching your DTE offering</strong></h3><p>You’ve determined that your DTE opportunity is worth pursuing, and you want to test the waters without overextending capital commitments. How do you get started? <br> <br>Through ZS’s extensive work with health system DTE pursuits, we observe that successful systems take a staged approach that is deliberate in strategy, narrow in early scope and rigorous in proof generation.</p><p><strong>Step 1: Define where you intend to win in DTE</strong></p><p>The first step is to decide what your health system is offering employers and why you should win. A viable DTE strategy aligns your system’s distinctive strengths with the structure of your local employer market.</p><p>Employer markets generally fall into three patterns:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/975/1*MdYVfMCRZ20kQvEe9aDwKQ.png" /></figure><p>Health systems that succeed in DTE typically pursue one of two strategic models:</p><ol><li>Deep specialty differentiation: Health systems build employer relevance around their recognized excellence in a high demand specialty area, such as cancer care, then expand nationally through partners and networks.</li><li>Comprehensive local portfolio: Health systems offer a comprehensive clinical portfolio- such as primary care, navigation and specialty access- to create durable, high-touch relationships with local employers.</li></ol><p>Choosing intentionally clarifies investment priorities, partnership strategy and governance while avoiding the pitfalls of aimless experimentation.</p><p><strong>Step 2: Operationalize a pilot with an anchor employer</strong></p><p>The next step is to launch a minimum viable pilot with an early-adopter customer to generate proof points. This pilot should be intentionally narrow (e.g., dedicated care navigation with reserved appointment capacity) and designed to answer a few critical questions:</p><ul><li>Can we operationalize an employer-focused service?</li><li>Can we deliver measurable financial and clinical value?</li><li>Can we earn the trust of an anchor employer?</li><li>Does the business case justify scaling?</li></ul><p>Early adopter customers are often the health system’s own self-insured population, given an annual spend in the hundreds of millions, or a large employer/union with a highly concentrated local workforce.</p><p>Regardless of the avenue, hardening the model while demonstrating tangible financial and clinical value is essential to winning the next set of customers and unlocking the next tranche of capital from your board.</p><h3><strong>The bottom line: DTE is a strategic growth engine</strong></h3><p>DTE is not a pricing workaround, side project or short-term margin patch. It’s a strategic choice to become accountable to employers for workforce health and cost performance. It can be a path to durable growth for systems that are willing to invest in employer-grade capabilities, but not for those dabbling without commitment.</p><h3><strong>About the authors:</strong></h3><p><strong>Sama Kadakia</strong> is a ZS strategy leader focused on helping health plans, health systems and healthcare services vendors design clinical, analytics and affordability solutions to meet the needs of employer‑sponsored healthcare. <br> <br><strong>Kim Quigley</strong> is a ZS executive advisor and former GM at Mt. Sinai Solutions in NYC, where she oversaw population health, direct-to-employer and specialty Rx solutions. Having run and managed direct-to-employer solutions as a health system leader, she advises health system executives on designing, launching and operating these businesses.</p><p><strong>Tina Chaudhry</strong> is a ZS health system practice leader specializing in helping health systems evaluate and operationalize business model innovations. She has partnered with health systems to define direct-to-consumer, direct-to-employer, value-based care and specialty Rx solutions.</p><p><strong>Vicky Chou i</strong>s a ZS Principal and global digital health practice leader. Vicky helps healthcare organizations design, launch and commercialize digital health solutions and has served in interim chief commercial officer roles for her former clients.</p><p><a href="https://www.zs.com/insights?utm_source=medium&amp;utm_medium=organic&amp;utm_campaign=insights-medium-promotion&amp;utm_term=20230926&amp;utm_content=insights">Read more insights from ZS.</a></p><p><em>This article reflects our personal views. They do not necessarily represent any official position of ZS.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=42044ac47491" width="1" height="1" alt=""><hr><p><a href="https://medium.com/zs-associates/is-direct-to-employer-a-growth-engine-or-costly-distraction-for-health-systems-42044ac47491">Is direct-to-employer a growth engine or costly distraction for health systems?</a> was originally published in <a href="https://medium.com/zs-associates">ZS Associates</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[How health systems are turning innovation into competitive advantage]]></title>
            <link>https://medium.com/zs-associates/how-health-systems-are-turning-innovation-into-competitive-advantage-cc2e807ad0cf?source=rss-7fa723e00fae------2</link>
            <guid isPermaLink="false">https://medium.com/p/cc2e807ad0cf</guid>
            <category><![CDATA[diversification]]></category>
            <category><![CDATA[innovation]]></category>
            <category><![CDATA[hospital]]></category>
            <category><![CDATA[health-systems]]></category>
            <category><![CDATA[strategy]]></category>
            <dc:creator><![CDATA[Sama Kadakia]]></dc:creator>
            <pubDate>Mon, 02 Mar 2026 23:25:52 GMT</pubDate>
            <atom:updated>2026-03-12T17:14:52.966Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*8vd_UnPaANnTxuC9vT4nPQ.jpeg" /></figure><p>By: <a href="https://www.linkedin.com/in/syed-rahman1?trk=public_post-text">Nishi Rahman</a>, <a href="https://www.linkedin.com/in/lizchau/">Liz Chau</a>, <a href="https://www.linkedin.com/in/samakadakia/">Sama Kadakia</a>, <a href="https://www.linkedin.com/in/tinachaudhry/">Tina Chaudhry</a> and <a href="https://www.linkedin.com/in/vickyzhouphd/">Vicky Zhou, PhD</a></p><p>The traditional health system growth model is reaching its limit. In a <a href="https://www.fiercehealthcare.com/providers/hospitals-operations-wrap-2025-solid-footing-face-payer-mix-bad-debt-headwinds-2026">staggering 1% margin reality</a> the old playbook of growth by scale–adding geographies, service lines, physician practices and negotiation leverage–is no longer sufficient.</p><p>Today’s health systems operate in persistent volatility: labor costs remain elevated, reimbursement continues to tighten and payers actively steer volume. Competition no longer comes only from neighboring systems, but from retail entrants, digital-first platforms and private equity-backed specialists. Technology is redefining access, care delivery and patient expectations — from agentic AI embedded in workflows to cell and gene therapies (CGT) reshaping specialty economics.</p><p>In this environment, scale alone is insufficient.</p><p>Forward-looking systems are shifting from scale to leverage — using innovation not as a side initiative, but as a mechanism to strengthen the enterprise, reduce structural cost and create new sources of advantage.</p><p>We can look to the NFL as an example.</p><p><strong><em>From scale to leverage: what health systems can learn from the NFL</em></strong></p><p>In professional football’s early years, revenue was constrained by stadium capacity. Owners originally feared that broadcasting games would cannibalize ticket sales. However, instead of optimizing physical capacity, the NFL centralized media rights, expanded distribution and rewired its economic model.</p><p>The result: revenue no longer tied to seats.</p><p>In 2026, just <a href="https://www.radiotimes.com/tv/sport/nfl/super-bowl-2026-attendance/">70,000 fans</a> filled Levi’s stadium for Super Bowl LX. <a href="https://www.nytimes.com/athletic/7036613/2026/02/10/super-bowl-ratings-nfl-nbc-bad-bunny/">Yet the second quarter alone reached 137.8 million viewers–the highest peak viewership in US history.</a> The game generated hundreds of millions of social media impressions and expanded the NFL’s global footprint.</p><p>The league built leverage beyond its physical infrastructure.</p><p>Health systems face a similar inflection point. They can continue to defend a facility-based, volume-dependent model–or they can build advantage beyond it.</p><p>Innovation, when structured deliberately, creates that leverage. It can:</p><ul><li>Strengthen the core operating engine</li><li>Reduce structural cost</li><li>Improve access and experience</li><li>Deepen payer and employer relationships</li><li>Diversify revenue streams</li><li>Extend brand beyond geography</li></ul><p>But innovation without clarity becomes fragmentation: isolated pilots, underfunded teams and exhausted clinicians.</p><h3><strong>How health systems are operationalizing innovation</strong></h3><p>Across ZS’s work with health systems nationally, three distinct innovation archetypes consistently emerge.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*7Hg6BNEec9M1tseNTuyGyw.jpeg" /><figcaption>Figure 1 — The 3 innovation archetypes</figcaption></figure><p><strong>Archetype 1: Innovation idea lab</strong></p><p><em>Best for systems prioritizing culture, engagement and recruiting top clinician talent over near-term financial return.</em></p><p>For many health systems, innovation begins with a common challenge: ideas are abundant, but structure and capital are not. The innovation idea lab addresses this by formalizing how ideas surface and progress. Clinicians and staff propose solutions through digital platforms, hackathons or internal grants. The goal is not building the next unicorn but instead creating a credible pathway for intrapreneurship.</p><p>Effective idea labs invest in governance, modest funding pools, protected time and transparent evaluation criteria. They avoid becoming a “black box” where ideas disappear by closing the loop — sharing outcomes, celebrating progress and supporting pilots with project management and technical resources.</p><p>One large academic system in the Midwest established a dedicated innovation institute that connected physicians with startups and physical workspaces. Projects ranged from AI-enabled radiology tools to exploratory concepts like drone-based drug delivery. Direct financial returns were modest, but the system’s reputation rose, boosting recruitment and securing a 8-figure donation.</p><p><strong><em>Value generated</em></strong></p><p>Primarily cultural. Idea labs drive workforce engagement, incremental operational improvements and a reputation as a forward-looking employer. Direct financial upside is limited.</p><p><strong><em>Risks and trade-offs</em></strong></p><p>This model is intentionally low risk, which also caps financial upside. Without disciplined follow-through, idea labs can erode trust. And because enterprise-wide change management is typically out of scope, solutions often remain siloed rather than scaling across the system.</p><p><strong>Archetype 2: System problem solver</strong></p><p><em>Best for systems using innovation as a vehicle for enterprise transformation and optimizing the way care is delivered today.</em></p><p>In this model, innovation is embedded in enterprise strategy and overseen by executive leadership. The focus is pragmatic: solving the system’s most pressing operational constraints.</p><p>These teams function less like venture studios and more like transformation engines. They tackle access bottlenecks, workforce friction, throughput constraints and cost inefficiencies. Commercialization outside the system is not the goal — strengthening the core business is, tackling cross-cutting initiatives with no clear home: agentic AI embedded in clinical workflows, document authoring platforms, or cell and gene therapy program scaling.</p><p>A large community system in the Northeast institutionalized this approach by establishing three innovation labs focused on business, care delivery and information transformation. Reporting directly to the CEO, the function was tightly linked to system strategy and backed by approximately $30M in operational investment. By integrating early‑stage solutions, the system secured preferential vendor arrangements–including one of the largest U.S. deployments of the AI scribing platform Suki–while streamlining administrative costs and building efficiencies to compete in a market dominated by academic medical centers.</p><p><strong><em>Value generated</em></strong><em> </em><br>Enterprise-wide cost improvement, productivity gains, enhanced patient access and workforce experience. Over time, these translate into margin expansion, revenue capture and differentiated patient experience.</p><p><strong><em>Risks and trade-offs</em></strong><em> </em><br>The primary risk is underestimating the lift. Scaling transformation requires far more than installing technology–it demands executive sponsorship, disciplined governance and sustained change management. Without clear accountability, projects stall. Without incentives and reporting structures, adoption lags. Without cross-functional capabilities spanning strategy, operations, IT, clinical leadership and change management, innovation devolves into disconnected pilots. This is not a lightweight model; it is an organizational commitment.</p><p><strong>Archetype 3: Big strategic bets</strong></p><p><em>Best for systems using innovation to future‑proof the organization and reshape long‑term positioning.</em></p><p>For systems making big bets, innovation becomes a vehicle to build new businesses, enter adjacent markets and diversify revenue beyond traditional care delivery.</p><p>These systems pursue eight-figure or larger opportunities, target new customer segments and extend influence beyond hospital walls. Big bets can take several forms: care model reinvention, direct-to-employer offerings, data as a product to pharma, tech-enabled navigation platforms or commercialization of differentiated assets.</p><p>The ambition is clear: own assets competitors cannot replicate and insulate the core business.</p><p>A specialty cancer center in the West exemplified this approach through AccessHope, a spin-off serving employers directly. By commercializing its differentiated cancer capabilities and partnering with other NCI designated centers, AccessHope reached approximately 9 million covered lives across more than 700+ organizations, including 70+ Fortune 500 companies, generating high eight-figure revenues. Payer relationships evolved into strategic partnerships, brand stature rose nationally, and the system became a must-have in-network partner.</p><p>Similar models are emerging in advanced therapeutics, specialty navigation and consumer-facing digital front doors, where systems extend their brand and clinical assets beyond traditional referral patterns.</p><p><strong><em>Value generated</em></strong></p><p>Beyond revenue, the deeper value is strategic repositioning. Big bets diversify fee-for-service risk, deepen payer relationships, elevate the brand, and create new patient acquisition channels. When executed well they create a flywheel effect, which improves payer mix and increases patient stickiness. Systems shift from regional providers to must-have strategic partners.</p><p><strong><em>Risks and trade-offs</em></strong></p><p>Big bets require the highest level of discipline. They demand rigorous market diligence, incubation protected from short-term pressures and leaders capable of sustaining a long-term vision. Investments are significant, cannibalization risk is real, and many systems must build or acquire go-to-market capabilities. Successful organizations manage this through portfolio governance, stage-gated capital allocation and clear right-to-win criteria grounded in differentiated assets and market economics. Without visible executive sponsorship and sufficient risk tolerance, large-scale bets rarely survive margin pressure.</p><h3><strong>Turning innovation into a competitive advantage</strong></h3><p>Across all three archetypes, the systems that see impact share one defining trait: <strong>clarity</strong>.</p><p>Leaders who turn innovation into competitive advantage can clearly answer four questions:</p><ol><li>What problem is innovation solving for our system today?</li><li>Which efforts strengthen the core, and which are designed for new growth?</li><li>Who has decision rights and when do we stop?</li><li>What capabilities are we deliberately building for the next five years?</li></ol><p>In our experience, systems that succeed treat innovation as a portfolio — balancing core optimization and new growth with explicit capital allocation and measurable value creation. Innovation becomes less about choosing the “right” archetype and more about aligning the model to the organization’s economic reality, risk tolerance and strategic ambition.</p><p><strong>From reacting to change to shaping it</strong></p><p>The next era of healthcare will be defined less by scale and more by adaptability.</p><p>Innovation, approached with discipline and economic clarity, allows health systems to move from reacting to external pressures to shaping their own and the market’s trajectory.</p><p>For leaders, the choice is not whether to innovate, but how to do so deliberately.</p><p>Systems that hesitate will find their future defined for them. Systems that act will shape their own.</p><p><a href="https://www.zs.com/insights?utm_source=medium&amp;utm_medium=organic&amp;utm_campaign=insights-medium-promotion&amp;utm_term=20230926&amp;utm_content=insights">Read more insights from ZS.</a></p><p><em>This article reflects our personal views. They do not necessarily represent any official position of ZS.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=cc2e807ad0cf" width="1" height="1" alt=""><hr><p><a href="https://medium.com/zs-associates/how-health-systems-are-turning-innovation-into-competitive-advantage-cc2e807ad0cf">How health systems are turning innovation into competitive advantage</a> was originally published in <a href="https://medium.com/zs-associates">ZS Associates</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>